Company / Cash per Share
PALVELLA THERAPEUTICS, INC. Cash per Share History
FY2015-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Cash per Share
$37.56
FY2024
5-year range
$0.10 / $37.56
FY2020-FY2024
Trend
+37978.9%
vs FY2023
Sector context
#4 of 205
Health Care
What the data says
Cash per Share changed +37979% YoY in FY2024, a notable deviation from the 9-year average annual change of +4215%.
Based on SEC 10-K filings.
37.56 in FY2024 with a 5-year CAGR of +100.8%. Top quartile in the Health Care sector.
Improved from $0.53 to $37.56 over the past 2 years.
Health Care sector context is included.
Cash per Share over time
Growth rates
- 3-Year CAGR
- +161.4%
- 5-Year CAGR
- +100.8%
- 10-Year CAGR
- -
Sector benchmark
Top 2% in Health CareTop 2% of 205This company $37.56 Sector average $67.98
▼
-44.7% below sector average
Key checks
Key Insights
- In FY2024, cash per share increased 37978.9% year-over-year.
- Ranks #4 out of 205 companies in the Health Care sector.
- Lowest cash per share in the period was in FY2023.
Company context
Key Data Points
- Altman Z-Score 1.15 (distress zone, below 1.8 threshold)
- Strong profit margin: 43.7%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Cash per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | $37.56 | +37978.9% |
| FY2023 | $0.10 | -81.6% |
| FY2022 | $0.53 | -74.6% |
| FY2021 | $2.10 | +64.8% |
| FY2020 | $1.28 | +11.0% |
| FY2019 | $1.15 | -30.9% |
| FY2018 | $1.66 | +143.9% |
| FY2017 | $0.68 | -7.5% |
| FY2016 | $0.74 | -65.2% |
| FY2015 | $2.12 | +35.6% |
As of FY2024 · SEC 10-K Annual Filings · Updated Jun 30, 2026